← Open Payments lookup

KRISTEN KICINSKI: Open Payments

NPI 1356041032 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,455 in 79 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $756 · 2025 $1,455

Food & beverage: $1,455
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$260
Otsuka America Pharmaceutical, Inc.12$246
ABBVIE INC.18$207
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$183
Janssen Pharmaceuticals, Inc6$167
Alkermes, Inc.5$105
E.R. Squibb & Sons, L.L.C.4$101
Vanda Pharmaceuticals Inc.2$51
Braeburn Inc.2$42
Supernus Pharmaceuticals, Inc.2$39

Products named: VRAYLAR, CAPLYTA, REXULTI, AUSTEDO XR, ARISTADA, COBENFY, SPRAVATO, INVEGA SUSTENNA.

Industry payments across WA — which companies pay providers there.